{"id":"W4309331420","doi":"10.1016/j.waojou.2022.100716","title":"Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria","year":2022,"lang":"en","type":"article","venue":"World Allergy Organization Journal","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Novartis Animal Health; BioCryst; AstraZeneca; Aimmune Therapeutics; CSL Behring; Genentech; Teva Pharmaceutical Industries; Novartis Pharma; Novartis; Amgen; Pfizer; GlaxoSmithKline","keywords":"Angioedema; Medicine; Omalizumab; Placebo; Dermatology Life Quality Index; Internal medicine; Quality of life (healthcare); Chronic urticaria; Gastroenterology; Dermatology; Disease; Immunology; Pathology; Antibody; Immunoglobulin E","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001161991,0.0001149099,0.0002342045,0.0002586046,0.000290834,0.00002389778,0.0000717898,0.00002828805,0.001524392],"category_scores_gemma":[0.0001526334,0.00009729983,0.00003405481,0.0007549374,0.00006501907,0.00009081436,0.00006567159,0.0003660798,0.000002820905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002219431,"about_ca_system_score_gemma":0.0005530694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002167995,"about_ca_topic_score_gemma":0.00009452766,"domain_scores_codex":[0.9987382,0.0001251261,0.0004179806,0.0001659003,0.0003729218,0.0001798282],"domain_scores_gemma":[0.9991263,0.0000383793,0.0001899929,0.0001446304,0.0002066206,0.0002941097],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001743373,0.001258251,0.9865285,0.00004087602,0.001318521,0.0004040929,0.0009534843,0.001330564,0.001144686,0.004067335,0.0005665183,0.0006438303],"study_design_scores_gemma":[0.003914571,0.0002616161,0.9943101,0.00004231291,0.0002174557,0.0001452239,0.0001044346,0.0001370895,0.00001791197,0.0001058715,0.0006121151,0.0001312352],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970217,0.0003953214,0.0001814318,0.001874835,0.0001481182,0.0001995282,0.00001556609,0.00002456557,0.0001389663],"genre_scores_gemma":[0.9988333,0.00006009043,0.0001303636,0.0002631429,0.00007377898,0.000004191206,0.00009841457,0.0000282545,0.0005084539],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007781694,"threshold_uncertainty_score":0.9993883,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006391261117745826,"score_gpt":0.2169185174119093,"score_spread":0.2105272562941634,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}